Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoring

• Autori principali: Ângela Albuquerque-Castro (Autore), Catarina Macedo-Silva (Autore), Rúben Oliveira-Sousa (Autore), Vera Constâncio (Autore), João Lobo (Autore), Isa Carneiro (Autore), Rui Henrique (Autore), Carmen Jerónimo (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2024-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Accurate prostate cancer (PCa) patient diagnosis and risk assessment are key to ensure the best outcome. Currently, low- and favorable intermediate-risk PCa patients may be offered AS due to the indolent nature of the disease. Nonetheless, deciding between active surveillance and curative-i...